 | • レポートコード：QY2207C3823 • 出版社/出版日：QYResearch / 2022年7月11日 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Multi User | ￥1,087,800 (USD7,350) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症のパンデミックにより、世界のエクソソーム療法の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にエクソソーム療法の世界市場のxxx％を占める「直接治療」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国のエクソソーム療法の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのエクソソーム療法市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのエクソソーム療法市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 エクソソーム療法のグローバル主要メーカーには、United Therapeutics Corporation、Codiak BioSciences、EngEx™、Esperite Group、ArunA Biomedical、Evox Therapeutics、NeurExo Sciences、Tavec Pharmaceuticals、AEGLE Therapeutics、Avalon GloboCare、AlligatorBioscience、Capricor Therapeutics、Stem Cell Medicine、CellTex Therapeuticsなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 エクソソーム療法市場は、種類と用途によって区分されます。世界のエクソソーム療法市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 直接治療、ドラッグデリバリービークル 【用途別セグメント】 病院、クリニック、研究機関 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - エクソソーム療法製品概要 - 種類別市場（直接治療、ドラッグデリバリービークル） - 用途別市場（病院、クリニック、研究機関） - 調査の目的 ・エグゼクティブサマリー - 世界のエクソソーム療法販売量予測2017-2028 - 世界のエクソソーム療法売上予測2017-2028 - エクソソーム療法の地域別販売量 - エクソソーム療法の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別エクソソーム療法販売量 - 主要メーカー別エクソソーム療法売上 - 主要メーカー別エクソソーム療法価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（直接治療、ドラッグデリバリービークル） - エクソソーム療法の種類別販売量 - エクソソーム療法の種類別売上 - エクソソーム療法の種類別価格 ・用途別市場規模（病院、クリニック、研究機関） - エクソソーム療法の用途別販売量 - エクソソーム療法の用途別売上 - エクソソーム療法の用途別価格 ・北米市場 - 北米のエクソソーム療法市場規模（種類別、用途別） - 主要国別のエクソソーム療法市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのエクソソーム療法市場規模（種類別、用途別） - 主要国別のエクソソーム療法市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のエクソソーム療法市場規模（種類別、用途別） - 主要国別のエクソソーム療法市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のエクソソーム療法市場規模（種類別、用途別） - 主要国別のエクソソーム療法市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのエクソソーム療法市場規模（種類別、用途別） - 主要国別のエクソソーム療法市場規模（トルコ、サウジアラビア） ・企業情報 United Therapeutics Corporation、Codiak BioSciences、EngEx™、Esperite Group、ArunA Biomedical、Evox Therapeutics、NeurExo Sciences、Tavec Pharmaceuticals、AEGLE Therapeutics、Avalon GloboCare、AlligatorBioscience、Capricor Therapeutics、Stem Cell Medicine、CellTex Therapeutics ・産業チェーン及び販売チャネル分析 - エクソソーム療法の産業チェーン分析 - エクソソーム療法の原材料 - エクソソーム療法の生産プロセス - エクソソーム療法の販売及びマーケティング - エクソソーム療法の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - エクソソーム療法の産業動向 - エクソソーム療法のマーケットドライバー - エクソソーム療法の課題 - エクソソーム療法の阻害要因 ・主な調査結果 |
Exosome technology can directly release specific miRNAs into tumor cells for the treatment of cholangiocarcinoma.
Market Analysis and Insights: Global Exosome Therapy Market
The global Exosome Therapy market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Direct Treatment accounting for % of the Exosome Therapy global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital segment is altered to an % CAGR throughout this forecast period.
China Exosome Therapy market size is valued at US$ million in 2021, while the North America and Europe Exosome Therapy are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Exosome Therapy landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Exosome Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Exosome Therapy market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Exosome Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Exosome Therapy market.
Global Exosome Therapy Scope and Market Size
Exosome Therapy market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Exosome Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Direct Treatment
Drug Delivery Vehicle
Segment by Application
Hospital
Clinic
Research Institutions
By Company
United Therapeutics Corporation
Codiak BioSciences
EngEx™
Esperite Group
ArunA Biomedical
Evox Therapeutics
NeurExo Sciences
Tavec Pharmaceuticals
AEGLE Therapeutics
Avalon GloboCare
AlligatorBioscience
Capricor Therapeutics
Stem Cell Medicine
CellTex Therapeutics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Exosome Therapy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Direct Treatment
1.2.3 Drug Delivery Vehicle
1.3 Market by Application
1.3.1 Global Exosome Therapy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Research Institutions
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Exosome Therapy Market Perspective (2017-2028)
2.2 Exosome Therapy Growth Trends by Region
2.2.1 Exosome Therapy Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Exosome Therapy Historic Market Size by Region (2017-2022)
2.2.3 Exosome Therapy Forecasted Market Size by Region (2023-2028)
2.3 Exosome Therapy Market Dynamics
2.3.1 Exosome Therapy Industry Trends
2.3.2 Exosome Therapy Market Drivers
2.3.3 Exosome Therapy Market Challenges
2.3.4 Exosome Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Exosome Therapy Players by Revenue
3.1.1 Global Top Exosome Therapy Players by Revenue (2017-2022)
3.1.2 Global Exosome Therapy Revenue Market Share by Players (2017-2022)
3.2 Global Exosome Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Exosome Therapy Revenue
3.4 Global Exosome Therapy Market Concentration Ratio
3.4.1 Global Exosome Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Exosome Therapy Revenue in 2021
3.5 Exosome Therapy Key Players Head office and Area Served
3.6 Key Players Exosome Therapy Product Solution and Service
3.7 Date of Enter into Exosome Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Exosome Therapy Breakdown Data by Type
4.1 Global Exosome Therapy Historic Market Size by Type (2017-2022)
4.2 Global Exosome Therapy Forecasted Market Size by Type (2023-2028)
5 Exosome Therapy Breakdown Data by Application
5.1 Global Exosome Therapy Historic Market Size by Application (2017-2022)
5.2 Global Exosome Therapy Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Exosome Therapy Market Size (2017-2028)
6.2 North America Exosome Therapy Market Size by Type
6.2.1 North America Exosome Therapy Market Size by Type (2017-2022)
6.2.2 North America Exosome Therapy Market Size by Type (2023-2028)
6.2.3 North America Exosome Therapy Market Share by Type (2017-2028)
6.3 North America Exosome Therapy Market Size by Application
6.3.1 North America Exosome Therapy Market Size by Application (2017-2022)
6.3.2 North America Exosome Therapy Market Size by Application (2023-2028)
6.3.3 North America Exosome Therapy Market Share by Application (2017-2028)
6.4 North America Exosome Therapy Market Size by Country
6.4.1 North America Exosome Therapy Market Size by Country (2017-2022)
6.4.2 North America Exosome Therapy Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Exosome Therapy Market Size (2017-2028)
7.2 Europe Exosome Therapy Market Size by Type
7.2.1 Europe Exosome Therapy Market Size by Type (2017-2022)
7.2.2 Europe Exosome Therapy Market Size by Type (2023-2028)
7.2.3 Europe Exosome Therapy Market Share by Type (2017-2028)
7.3 Europe Exosome Therapy Market Size by Application
7.3.1 Europe Exosome Therapy Market Size by Application (2017-2022)
7.3.2 Europe Exosome Therapy Market Size by Application (2023-2028)
7.3.3 Europe Exosome Therapy Market Share by Application (2017-2028)
7.4 Europe Exosome Therapy Market Size by Country
7.4.1 Europe Exosome Therapy Market Size by Country (2017-2022)
7.4.2 Europe Exosome Therapy Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Exosome Therapy Market Size (2017-2028)
8.2 Asia-Pacific Exosome Therapy Market Size by Type
8.2.1 Asia-Pacific Exosome Therapy Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Exosome Therapy Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Exosome Therapy Market Share by Type (2017-2028)
8.3 Asia-Pacific Exosome Therapy Market Size by Application
8.3.1 Asia-Pacific Exosome Therapy Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Exosome Therapy Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Exosome Therapy Market Share by Application (2017-2028)
8.4 Asia-Pacific Exosome Therapy Market Size by Region
8.4.1 Asia-Pacific Exosome Therapy Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Exosome Therapy Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Exosome Therapy Market Size (2017-2028)
9.2 Latin America Exosome Therapy Market Size by Type
9.2.1 Latin America Exosome Therapy Market Size by Type (2017-2022)
9.2.2 Latin America Exosome Therapy Market Size by Type (2023-2028)
9.2.3 Latin America Exosome Therapy Market Share by Type (2017-2028)
9.3 Latin America Exosome Therapy Market Size by Application
9.3.1 Latin America Exosome Therapy Market Size by Application (2017-2022)
9.3.2 Latin America Exosome Therapy Market Size by Application (2023-2028)
9.3.3 Latin America Exosome Therapy Market Share by Application (2017-2028)
9.4 Latin America Exosome Therapy Market Size by Country
9.4.1 Latin America Exosome Therapy Market Size by Country (2017-2022)
9.4.2 Latin America Exosome Therapy Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Exosome Therapy Market Size (2017-2028)
10.2 Middle East & Africa Exosome Therapy Market Size by Type
10.2.1 Middle East & Africa Exosome Therapy Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Exosome Therapy Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Exosome Therapy Market Share by Type (2017-2028)
10.3 Middle East & Africa Exosome Therapy Market Size by Application
10.3.1 Middle East & Africa Exosome Therapy Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Exosome Therapy Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Exosome Therapy Market Share by Application (2017-2028)
10.4 Middle East & Africa Exosome Therapy Market Size by Country
10.4.1 Middle East & Africa Exosome Therapy Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Exosome Therapy Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 United Therapeutics Corporation
11.1.1 United Therapeutics Corporation Company Details
11.1.2 United Therapeutics Corporation Business Overview
11.1.3 United Therapeutics Corporation Exosome Therapy Introduction
11.1.4 United Therapeutics Corporation Revenue in Exosome Therapy Business (2017-2022)
11.1.5 United Therapeutics Corporation Recent Developments
11.2 Codiak BioSciences
11.2.1 Codiak BioSciences Company Details
11.2.2 Codiak BioSciences Business Overview
11.2.3 Codiak BioSciences Exosome Therapy Introduction
11.2.4 Codiak BioSciences Revenue in Exosome Therapy Business (2017-2022)
11.2.5 Codiak BioSciences Recent Developments
11.3 EngEx™
11.3.1 EngEx™ Company Details
11.3.2 EngEx™ Business Overview
11.3.3 EngEx™ Exosome Therapy Introduction
11.3.4 EngEx™ Revenue in Exosome Therapy Business (2017-2022)
11.3.5 EngEx™ Recent Developments
11.4 Esperite Group
11.4.1 Esperite Group Company Details
11.4.2 Esperite Group Business Overview
11.4.3 Esperite Group Exosome Therapy Introduction
11.4.4 Esperite Group Revenue in Exosome Therapy Business (2017-2022)
11.4.5 Esperite Group Recent Developments
11.5 ArunA Biomedical
11.5.1 ArunA Biomedical Company Details
11.5.2 ArunA Biomedical Business Overview
11.5.3 ArunA Biomedical Exosome Therapy Introduction
11.5.4 ArunA Biomedical Revenue in Exosome Therapy Business (2017-2022)
11.5.5 ArunA Biomedical Recent Developments
11.6 Evox Therapeutics
11.6.1 Evox Therapeutics Company Details
11.6.2 Evox Therapeutics Business Overview
11.6.3 Evox Therapeutics Exosome Therapy Introduction
11.6.4 Evox Therapeutics Revenue in Exosome Therapy Business (2017-2022)
11.6.5 Evox Therapeutics Recent Developments
11.7 NeurExo Sciences
11.7.1 NeurExo Sciences Company Details
11.7.2 NeurExo Sciences Business Overview
11.7.3 NeurExo Sciences Exosome Therapy Introduction
11.7.4 NeurExo Sciences Revenue in Exosome Therapy Business (2017-2022)
11.7.5 NeurExo Sciences Recent Developments
11.8 Tavec Pharmaceuticals
11.8.1 Tavec Pharmaceuticals Company Details
11.8.2 Tavec Pharmaceuticals Business Overview
11.8.3 Tavec Pharmaceuticals Exosome Therapy Introduction
11.8.4 Tavec Pharmaceuticals Revenue in Exosome Therapy Business (2017-2022)
11.8.5 Tavec Pharmaceuticals Recent Developments
11.9 AEGLE Therapeutics
11.9.1 AEGLE Therapeutics Company Details
11.9.2 AEGLE Therapeutics Business Overview
11.9.3 AEGLE Therapeutics Exosome Therapy Introduction
11.9.4 AEGLE Therapeutics Revenue in Exosome Therapy Business (2017-2022)
11.9.5 AEGLE Therapeutics Recent Developments
11.10 Avalon GloboCare
11.10.1 Avalon GloboCare Company Details
11.10.2 Avalon GloboCare Business Overview
11.10.3 Avalon GloboCare Exosome Therapy Introduction
11.10.4 Avalon GloboCare Revenue in Exosome Therapy Business (2017-2022)
11.10.5 Avalon GloboCare Recent Developments
11.11 AlligatorBioscience
11.11.1 AlligatorBioscience Company Details
11.11.2 AlligatorBioscience Business Overview
11.11.3 AlligatorBioscience Exosome Therapy Introduction
11.11.4 AlligatorBioscience Revenue in Exosome Therapy Business (2017-2022)
11.11.5 AlligatorBioscience Recent Developments
11.12 Capricor Therapeutics
11.12.1 Capricor Therapeutics Company Details
11.12.2 Capricor Therapeutics Business Overview
11.12.3 Capricor Therapeutics Exosome Therapy Introduction
11.12.4 Capricor Therapeutics Revenue in Exosome Therapy Business (2017-2022)
11.12.5 Capricor Therapeutics Recent Developments
11.13 Stem Cell Medicine
11.13.1 Stem Cell Medicine Company Details
11.13.2 Stem Cell Medicine Business Overview
11.13.3 Stem Cell Medicine Exosome Therapy Introduction
11.13.4 Stem Cell Medicine Revenue in Exosome Therapy Business (2017-2022)
11.13.5 Stem Cell Medicine Recent Developments
11.14 CellTex Therapeutics
11.14.1 CellTex Therapeutics Company Details
11.14.2 CellTex Therapeutics Business Overview
11.14.3 CellTex Therapeutics Exosome Therapy Introduction
11.14.4 CellTex Therapeutics Revenue in Exosome Therapy Business (2017-2022)
11.14.5 CellTex Therapeutics Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer